165 related articles for article (PubMed ID: 1107604)
1. Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin.
Merrin C; Etra W; Wajsman Z; Baumgartner G; Murphy G
J Urol; 1976 Jan; 115(1):86-8. PubMed ID: 1107604
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin hydrochloride, cyclophosphamide, and 5-fluorouracil combination in advanced prostate and transitional cell carcinoma.
Collier D; Soloway MS
Urology; 1976 Nov; 8(5):459-64. PubMed ID: 982733
[TBL] [Abstract][Full Text] [Related]
3. Comparison of adriamycin (NSC-123127) and the combination of 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in advanced prostatic cancer: a preliminary report.
Eagan RT; Utz DC; Myers RP; Furlow WL
Cancer Chemother Rep; 1975; 59(1):203-7. PubMed ID: 1093666
[TBL] [Abstract][Full Text] [Related]
4. Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in the treatment of metastatic prostate cancer.
Eagan RT; Hahn RG; Myers RP
Cancer Treat Rep; 1976 Jan; 60(1):115-7. PubMed ID: 1000515
[No Abstract] [Full Text] [Related]
5. A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinoma.
Smalley RV; Bartolucci AA; Hemstreet G; Hester M
J Urol; 1981 Feb; 125(2):191-5. PubMed ID: 7206052
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy with methotrexate (NSC-740), adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and 5-fluorouracil (NSC19893) for adult solid tumors.
Stephens RL; Hoogstraten B
Cancer Chemother Rep; 1974; 58(6):943-5. PubMed ID: 4614901
[No Abstract] [Full Text] [Related]
7. Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer: a randomized trial.
Chlebowski RT; Hestorff R; Sardoff L; Weiner J; Bateman JR
Cancer; 1978 Dec; 42(6):2546-52. PubMed ID: 365313
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study.
Hoogstraten B; George SL; Samal B; Rivkin SE; Costanzi JJ; Bonnet JD; Thigpen T; Braine H
Cancer; 1976 Jul; 38(1):13-20. PubMed ID: 947510
[TBL] [Abstract][Full Text] [Related]
9. A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer.
Bennett JM; Byrne P; Desai A; White C; DeConti R; Vogel C; Krementz E; Muggia F; Doroshow J; Plotkin D
Invest New Drugs; 1985; 3(2):179-85. PubMed ID: 3894279
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy of advanced endometrial adenocarcinoma with adriamycin, cyclophosphamide, 5-fluorouracil, and medroxyprogesterone acetate.
Bruckner HW; Deppe G
Obstet Gynecol; 1977 Jul; 50(1 Suppl):10s-12s. PubMed ID: 876531
[TBL] [Abstract][Full Text] [Related]
11. Mitoxantrone combined to vincristine, cyclophosphamide and fluorouracil in advanced breast cancer.
Metz R; Delgado M; Keiling R; Cappelaere P; Armand JP; Prevot G; Misset JL; Grimbert J; Mathe G
Invest New Drugs; 1985; 3(2):163-6. PubMed ID: 4019119
[TBL] [Abstract][Full Text] [Related]
12. A comparative clinical trial of adriamycin and 5-fluorouracil in advanced prostatic cancer: prognostic factors and response.
DeWys WD; Begg CB; Brodovsky H; Creech R; Khandekar J
Prostate; 1983; 4(1):1-11. PubMed ID: 6340081
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic manipulation of Nb rat prostatic adenocarcinomas: chemotherapeutic evaluation of autonomous tumors.
Drago JR; Goldman LB; Maurer RE; Gershwin ME; Eckels DD
Invest Urol; 1979 Nov; 17(3):203-6. PubMed ID: 500317
[TBL] [Abstract][Full Text] [Related]
14. Failure of intensive combination therapy (cyclophosphamide, adriamycin, 5-fluorouracil) to control adenocarcinoma or large-cell anaplastic carcinoma of lung.
Taylor RE; Smith IE; Ford HT; Bryant BM; Casey AJ; Smyth JF
Cancer Chemother Pharmacol; 1980; 4(4):271-3. PubMed ID: 6254685
[TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced adenocarcinoma of the pancreas with combinations of streptozotocin plus 5-fluorouracil and streptozotocin plus cyclophosphamide.
Moertel CG; Douglas HO; Hanley J; Carbone PP
Cancer; 1977 Aug; 40(2):605-8. PubMed ID: 142579
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of advanced prostatic carcinoma with cyclophosphamide or 5-fluorouracil: results of first national randomized study.
Scott WW; Johnson DE; Schmidt JE; Gibbons RP; Prout GR; Joiner JR; Saroff J; Murphy GP
J Urol; 1975 Dec; 114(6):909-11. PubMed ID: 1104900
[TBL] [Abstract][Full Text] [Related]
17. Adriamycin in combination for the treatment of breast cancer: a Southwest Oncology Group study.
Tranum B; Hoogstraten B; Kennedy A; Vaughn CB; Samal B; Thigpen T; Rivkin S; Smith F; Palmer RL; Costanzi J; Tucker WG; Wilson H; Maloney TR
Cancer; 1978 Jun; 41(6):2078-83. PubMed ID: 657081
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of bladder carcinoma with cyclophosphamide and adriamycin.
Merrin C; Cartagena R; Wajsman Z; Baumgartner G; Murphy GP
J Urol; 1975 Dec; 114(6):884-7. PubMed ID: 1195468
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin and cyclophosphamide chemotherapy for disseminated endometrial cancer.
Seski JC; Edwards CL; Gershenson DM; Copeland LJ
Obstet Gynecol; 1981 Jul; 58(1):88-91. PubMed ID: 7195533
[TBL] [Abstract][Full Text] [Related]
20. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project.
Smalley RV; Carpenter J; Bartolucci A; Vogel C; Krauss S
Cancer; 1977 Aug; 40(2):625-32. PubMed ID: 329975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
